China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Bevacizumab Combined with Immunochemotherapy versus Immunochemotherapy Alone as First-L... Read More
China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Multicenter Clinical Study on the Accuracy of Quantitative CT (QCT) Bone Density Measur... Read More
China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical Efficacy Evaluation of Onlay Bone Grafting Technique versus Spilit Bone Block ... Read More
China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Research on the Effectiveness of an Early Activity Protocol Based on Virtual Reality Te... Read More
China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A randomized controlled trial on the effects of native DHA· Milk on intestinal microeco... Read More
China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the efficacy and safety of preoperative application of Tegileridine in achievi... Read More
China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Progressive Proprioceptive Training for Improving High-Speed Locomotor Adaptation Defic... Read More
China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Acute Physiological Load and Neuromuscular Responses to 15-Point vs. 21-Point Badminton... Read More
China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective Clinical Study of a Thiotepa-Containing Conditioning Regimen for Allogene... Read More
China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A single-arm, phase II, exploratory study of Culmerciclib in combination with letrozole... Read More